Study on Oxygen and Nitrous Oxide Use in Critically Ill Adults on Ventilators
- Substances:Nitrous OxideOxygen
Italy- Participants:18–64 years · 65+ years
- Substances:Nitrous Oxide
- Sponsor:Azienda Ospedaliero Universitaria Di Modena
Rare diseases
Investigational molecules
Locations
Back to Italy805 clinical trials in Florence, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
ItalyStudy on Letrozole vs. Chemotherapy (Carboplatin and Paclitaxel) for Patients with Advanced Low-Grade Serous Ovarian Cancer with Hormone Receptors
ItalyStudy on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
ItalyStudy of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma
ItalyStudy on the Effectiveness of Gilteritinib and Drug Combination for Patients with Relapsed or Refractory Acute Myeloid Leukemia
ItalyStudy on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease
ItalyStudy of Aficamten for Children with Symptomatic Obstructive Hypertrophic Cardiomyopathy
ItalyStudy on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation
ItalyStudy on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors
ItalyStudy on Acalabrutinib for Adults with Chronic Lymphocytic Leukemia and Heart Issues
ItalyStudy of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions
ItalyStudy on Rimegepant for Preventing Migraines in Children and Teens Aged 6 to 17
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for frontotemporal dementia, multiple sclerosis, and Dravet syndrome. Studies evaluate novel therapeutic approaches including DNL593 for FTD and frexalimab for relapsing MS.
Emphasis on safety assessment and long-term efficacy monitoring.
Comprehensive studies targeting various cancer types including colorectal cancer, breast cancer, and lung cancer. Trials explore combination therapies and novel treatment approaches.
Focus on targeted therapies and personalized treatment approaches.
Investigating treatments for psoriatic arthritis, Sjögren's syndrome, and systemic sclerosis. Research includes evaluation of new biologics and targeted therapies.
Studies aim to improve quality of life and disease management.
Studies examining treatments for COPD and respiratory infections, including evaluation of tezepelumab for moderate to severe COPD and prevention of RSV in infants.
Focus on improving respiratory outcomes and prevention strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.